Following is a summary of current health news briefs.
FDA approves Alexion's Ultomiris for another rare blood disease
The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc's treatment for a second rare blood disorder, the company said. The treatment, Ultomiris, has already been approved in the United States, Japan and the European Union to treat adults with blood disorder called paroxysmal nocturnal hemoglobinuria.
J&J recalls 33,000 bottles of baby powder as FDA finds asbestos in sample
Johnson & Johnson said on Friday it is recalling around 33,000 bottles of baby powder in the United States after U.S. health regulators found trace amounts of asbestos in samples taken from a bottle purchased online. J&J shares fell more than 6% to close at $127.70.
Early life stress tied to increased pain sensitivity later
People who were exposed to more sources of stress in the womb and early childhood may be more sensitive to pain by early adulthood than their counterparts with little or no exposure to stress early on, a recent study suggests. Researchers focused on stressful life events that might occur in children’s households during pregnancy or early childhood such as pregnancy complications, the death of a close friend or family member, marital problems or breakups, job loss or other financial hardships, or residential moves. Then, researchers tested pain sensitivity for 1,065 participants when they reached 22 years old.
Erdogan says he will never allow vaping, will block e-cigarettes in Turkey
Turkish President Tayyip Erdogan said on Sunday he will never allow electronic cigarette companies to produce their products in Turkey, urging Turks to drink tea instead. Speaking at an event against smoking in Istanbul, Erdogan said he had ordered his Trade Minister "never" to allow e-cigarettes in Turkey and said that tobacco companies were "getting rich by poisoning" people.
Sanofi pulls Zantac from U.S. and Canada after carcinogen found
Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity. The French drugmaker said it was working with health authorities to determine the level and extent of the recall, which it called a precautionary measure being taken due to possible contamination with a substance called N-nitrosodimethylamine (NDMA).
Opioid settlement talks fail, landmark trial expected Monday
A landmark trial over the U.S. opioid epidemic is on track to begin on Monday after drug companies and local governments failed to agree on a settlement on Friday that had been expected to be valued at around $50 billion. Top executives of the largest U.S. drug distributors and drugmaker Teva Pharmaceutical Industries Ltd left a Cleveland courthouse on Friday and lawyers for states and thousands of local governments said there was no agreement.